SML4008
Zuclopenthixol
≥98% (HPLC)
别名:
(Z)-4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol, 4-[(3Z)-3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C22H25ClN2OS
化学文摘社编号:
分子量:
400.96
UNSPSC Code:
12352200
MDL number:
NACRES:
NA.21
SMILES string
S1c2c(cc(cc2)Cl)\C(=C/CCN4CCN(CC4)CCO)\c3c1cccc3
InChI key
WFPIAZLQTJBIFN-DVZOWYKESA-N
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
Oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors.
Zuclopenthixol, a typical antipsychotic, is an oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors. Zuclopenthixol is approved in some countries for treatment of schizophrenia and other psychoses. Zuclopenthixol is a cis isomer of neuroleptic clopenthixol.
Zuclopenthixol, a typical antipsychotic, is an oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors. Zuclopenthixol is approved in some countries for treatment of schizophrenia and other psychoses. Zuclopenthixol is a cis isomer of neuroleptic clopenthixol.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Elham Sardari et al.
Multiple sclerosis and related disorders, 73, 104622-104622 (2023-03-24)
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting numerous people worldwide. While the relapsing subtypes of MS are to some extent treatable, the disease remains incurable leading to progressive disability. Limited efficacy of current small molecule drugs necessitates development
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
Cochrane database of systematic reviews (Online) null
Jianjun Li et al.
Journal of oncology, 2022, 5490461-5490461 (2022-01-25)
Esophagus cancer (ESCA) is the sixth most frequent cancer in males, with 5-year overall survival of 15%-25%. RNA modifications function critically in cancer progression, and m6A regulators are associated with ESCA prognosis. This study further revealed correlations between m6A and
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持